Mendelian randomization of immune cell phenotypes to discover potential drug targets for B-cell malignancy
Abstract Although treatment options for B-cell malignancies have expanded, many patients continue to face limited response rates, highlighting an urgent need for new therapeutic targets. To prioritize candidate drug targets for B-cell malignancies, we employed Mendelian Randomization to estimate pot...
Saved in:
| Main Authors: | Sina A. Beer, Molly Went, Charlie Mills, Codie Wood, Amit Sud, James M. Allan, Richard Houlston, Martin F. Kaiser |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-04-01
|
| Series: | Blood Cancer Journal |
| Online Access: | https://doi.org/10.1038/s41408-025-01277-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Appraising ascorbic acid as a chemoprevention agent for acute myeloid leukaemia using Mendelian Randomisation
by: Sina A. Beer, et al.
Published: (2024-10-01) -
Aurintricarboxylic acid inhibits the malignant phenotypes of drug-resistant cells via translation regulation
by: Keke Shang, et al.
Published: (2025-05-01) -
Mendelian randomization analysis of gut microbiota-immune cell interactions in malignant neoplasm of nasopharynx
by: Qicong Chen, et al.
Published: (2025-07-01) -
Discovering American History /
by: Kownslar, Allan O.
Published: (1967) -
Immune cell phenotypes as causal factors in liver disease progression revealed by Mendelian randomization
by: Jingtao Huang, et al.
Published: (2025-04-01)